Lung pathology in COVID-19

Marie-Christine Copin, Jean-Baptiste Gibier, Véronique Hofman, Paul Hofman

Source: Eur Respir Monogr 2021; 94: 86-100

Journal Issue: COVID-19

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Marie-Christine Copin, Jean-Baptiste Gibier, Véronique Hofman, Paul Hofman. Lung pathology in COVID-19. Eur Respir Monogr 2021; 94: 86-100

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Lung development Source: Eur Respir Monogr 2021; 91: 1-16 Year: 2021
Lung function Source: Eur Respir Monogr 2013; 62: 127-145 Year: 2013
Lung Micobiome in Lung Cancer Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020
Lung tumours Source: Eur Respir Monogr 2018; 79: 115-128 Year: 2018
Lung biopsy Source: ERS Course 2019 - Thoracoscopy and Pleural Techniques, April 2019 Year: 2019
Lung biopsy Source: ERS Course 2019 - Thoracoscopy and Pleural Techniques Year: 2019
An electron microscopic study of amelioration of radiation-induced lung injury by halofuginone Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014
Lung nodules Source: School Course 2014- Endoscopic ultrasound in the diagnosing and staging of lung cancer Year: 2014
Clinical effect of pirfenidone on incidence of lung carcinoma in chronic interstitial pneumonia Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014
Lung biopsy in the diagnostics of interstitial lung disease Source: Eur Respir J 2007; 30: Suppl. 51, 561s Year: 2007
Mucus production, lung inflammation and functional decay in IPF Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014
Lung cancer Source: Breathe 2016; 12: 392-399 Year: 2016